Susan R. Bailey, MD, immediate past president, AMA, welcomes Peter Marks, MD, PhD, Director of the Center for Biologics Evaluation and Research at the Food and Drug Administration (FDA), who will address a host of hot topics related to the fourth dose booster vaccine and provide updates on pediatric vaccine safety data. Hear the latest on who should receive the fourth dose—and when—and whether we’ll be seeing a vaccine for younger children soon.
Chapters:
00:00 Introduction
04:48 Topics to be Covered
05:44 Johnson and Johnson COVID-19 Vaccine EUA and Thrombosis with Thrombocytopenia Syndrome (TTS)
08:44 COVID-19 Vaccine Boosters
17:25 Boosters for New Variants
19:24 FDA Advisory Committee Update on Boosters
23:19 Pediatric Clinical Trial Data
27:54 COVID-19 Vaccines in Children Under 5
30:19 Upcoming Advisory Committee Meeting Agenda
32:21 Timing of COVID Boosters and Breakthrough Infections
34:10 Reasons to Postpone a 4th Booster Shot
37:33 Will there be diminishing returns from booster shots over time?
40:23 Mixing and Matching Boosters
42:12 Long Term Data on T-Cell Responses
44:06 Booster Recommendations for Pregnant Individuals
45:42 4th Dose Booster for Health Care Professionals
46:51 Should Individuals Under 50 Get a 4th Dose Booster?
47:36 Myocarditis Updates
51:16 Combination COVID and Flu Vaccine
54:59 COVID-19 Vaccine for Kids Under 5 Timeline
57:32 Is the COVID Vaccine Safe for Kids Under 5?
59:54 Closing Remarks
